GlycoSeLect - Dublin, Ireland

GlycoSeLect is an expert in the development and manufacturing of Recombinant Prokaryotic Lectins (RPLs), which are powerful tools for analyzing and selectively purifying glycosylated biomolecules. RPLs have many uses in a wide range of life science fields, such as basic research and development, glycobiology and glycoproteomics, biomarker discovery and biomedical diagnostics, the biopharmaceutical industry, vaccines, and cosmetics. GlycoSeLect's Recombinant Prokaryotic Lectins offer several advantages compared to other commercially available lectin products, such as simplified, rapid, and cost-effective production through recombinant expression in Escherichia coli, higher purity and consistent performance, genetically enhanced glycan binding properties (specificity and affinity), and scalable production to support large-scale applications.